Subject: MJNA Continues its Expo Tour in Miami

SCV Client Spotlight
MJNA Continues its Expo Tour in Miami
Hot Stock to WatchHot Stock to Watch


Company: Medical Marijuana Inc. (Pink Sheets: MJNA)


Last:

Price: 0.1467

Change (%): + 0.0002 (0.14)

Volume: 1,100,310
MJNA Chart

Medical Marijuana Inc.’s HempMedsPX to Exhibit at Miami Wholesale Expo 2013

HempMedsPX Will Exhibit Hemp-Based Cannabidiol (CBD) Products at Merchandise Show


SAN DIEGO, Sept. 25, 2013 (GLOBE NEWSWIRE) - Medical Marijuana Inc. (OTC Pink: MJNA) is pleased to inform shareholders and the general public that HempMedsPX - a corporate portfolio company of Medical Marijuana Inc. and the exclusive master distributor and contracted marketing company for CannaVest Corp. and Medical Marijuana Inc. - will be exhibiting cannabidiol (CBD)-rich hemp oil products at Miami Wholesale Expo 2013 at the Miami Airport Convention Center from September 30-October 2, 2013.

Miami Wholesale Expo 2013 is targeted to wholesalers and buyers of general merchandise in Florida and the Caribbean, the “Hub of the Americas.” The Miami Wholesale Expo is an annual destination for buyers, retailers, distributors and importers for the region, offering over 150 product categories to choose from before the holiday season.

Continue Reading

Top PerformerYesterday's Top Performer

Company:
Advanced Medical Isotope Corp. (OTCQB: ADMD)


End of Day:

Price: 0.045

Change (%): + 0.0039 (9.49)

Volume: 102,921
ADMD Chart

About Advanced Medical Isotope Corporation

Advanced Medical Isotope Corporation is a Washington State based company comprised of a brilliant team of radio-chemists, scientists and engineers, collaborating with national labs and universities to implement proprietary technologies capable of producing crucial medical isotopes on US soil.

By enabling physicians and empowering researchers to find isotope solutions, we are helping to lengthen the lives of Cancer patients and creating hope for a healthier future.

Company Information Sheet


Other Small Cap News


Company: MediSwipe Inc. (OTCQB: MWIP)


MediSwipe Inc. to Capitalize on Corporate Opportunity in Medicinal and Recreational Marijuana Financial Services Sector as Washington State Seeks Alternatives for Payment Solutions

LOS ANGELES, CA --(Marketwired - September 25, 2013) - MediSwipe Inc. (OTCQB: MWIP), the leader in Compassionate Care Technology Solutions for the medicinal marijuana industry, today announced that the Company will seek to capitalize on Washington State's announcement to seek banking partners for the state's new marijuana initiatives.

With a recent editorial being published in the Seattle Times regarding the state of Washington's bid to find a financial institution to provide safe medical marijuana-based banking, the spotlight has been cast upon multinational banking and financial services corporation, Bank of America. However, while many assume that Bank of America would be the first of its kind to provide a form of delivery and financial operating processes to the medical marijuana industry, MediSwipe Inc., has long established itself as the first publicly traded Company to provide financial services, and merchant processing for canna-businesses.

Continue Reading


Company: Plandaí Biotechnology, Inc. (OTCQB: PLPL)


Plandai Biotechnology, Inc. Executes Letter of Intent to Sell All Estimated 2014 Phytofare Limonoid Production

SEATTLE, WA--(Marketwired - Sep 25, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, today announced that it has executed a letter of intent with a major producer of nutraceutical cold and flu remedies under which all of 2014 estimated production capacity of Phytofare™ Limonoid Glycoside Complex, estimated at 15 tons, will be purchased. The letter of intent is subject to favorable results from a clinical trial which is expected to commence late in 2013.

Plandaí's Phytofare™ Limonoid Glycoside Complex is derived from lemons, utilizing the entire fruit -- pith, peel, pulp and juice -- and is rich in the entire spectrum of 170 phytochemicals including flavonoids, Vitamin C, and limonoid glycosides (antioxidants). Prior clinical investigations of citrus bioflavonoids showed improved wellness benefits in combating allergic and vasomotor rhinitis (common cold). This includes the lowering of chills, feverishness, headache or general aching, nasal stiffness or discharge, sore throat, cough and sputum expectoration.

Continue Reading


Market News


By Richard Hubbard: Reuters


Dollar slips, shares weak as U.S. budget worries weigh

LONDON (Reuters) - The dollar fell and world shares held near a one-week low on Wednesday as concerns over a potential government shutdown in Washington and mixed signals on U.S. monetary policy kept investors on edge.

A United States Senate vote is due later in the day on a motion that would allow the government to keep running beyond the end of the month when budgets are due to expire, though lawmakers have yet to find common ground.

Investors, wrong-footed by last week's shock decision by the Federal Reserve not to begin trimming its bond-buying stimulus, are also in flux over the central bank's next steps and what mixed signals from policymakers say about the strength of the economy.

Continue Reading


By Lee Brodie:
CNBC


Cramer: 12 reasons market remains afloat

The ability of this market to remain within a stone's throw of its all time high despite so many headwinds has astounded many investors. Not Cramer.

"When you get this kind of relative resilience in the face of what could be the worst Washington showdown of the Obama administration yet, you have to ask yourself where it is coming from. You have to try to figure out how the market can keep rolling higher."

Continue Reading

Like Us on FacebookFollow Us on Twitter

IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks